Pharma channel feed – Endpoints News

Pharma channel feed

Sahm Adrangi’s Kerrisdale knifes Proteostasis’ 'breakthrough' cystic fibrosis data in a brutal biotech short attack

8 years ago

Donald Trump promises (again) to slash drug prices substantially; 'and it’s going to be beautiful’

8 years ago

FDA OKs Hizentra for rare autoimmune disease CIDP

8 years ago

Dems, Republicans split on 340B drug pricing program in Senate hearing

8 years ago

China stocks the new trend? Loncar launches index

8 years ago

Swapping stock and cash, Ionis turns to closely-controlled Akcea for a deal on spurned drug inotersen

8 years ago

FDA slaps a hold on Solid Bio's gene therapy for Duchenne MD in wake of safety alert

8 years ago

Lousy year for shareholders, but Allergan CEO Brent Saunders sprints past Gorsky, Gonzalez with $32M pay package

8 years ago

'Right-to-try' bill fails to muster votes, dies in the House (for now)

8 years ago

Teva calls off CGRP drug discovery and development pact, returns preclinical asset to Sosei

8 years ago

Proteostasis stock soars on cystic fibrosis breakthrough status

8 years ago

Busy Sanofi takes a pass on one of Alnylam’s rare disease drugs, FDA offers ‘breakthrough’ status for PhIII

8 years ago

Biogen is hustling a schizophrenia drug into PhIIb after Pfizer lets it go in $590M CNS fire sale

8 years ago

Regeneron boosted, rival Esperion slammed as investors scramble to catch up to a PCSK9 price war

8 years ago

Praluent Odyssey: Regeneron/Sanofi gun for market breakout with first-ever mortality benefit — and a big price discount

8 years ago

Senators heap abuse on Allergan's attempt at an end run around patent reviews, offer bill to stop 'sham'

8 years ago

Sanofi is jettisoning its infectious disease unit to Evotec — handing over cash, staff and a pipeline

8 years ago

Doubling down on the Keytruda franchise, Merck pays $300M and promises $5B-plus to partner with Eisai on its budding cancer star

8 years ago

Pfizer breaks off a 5-year, $635M collaboration deal with CytomX, with nothing to show for it

8 years ago

'Rigged' payment schemes by insurers and PBMs is blocking the switch to biosimilars, says FDA commissioner

8 years ago

Flanked by rivals and skeptics, Esperion flips positive data on first PhIII for a potentially game-changing cholesterol pill

8 years ago

Metavant makes a debut: Vivek Ramaswamy launches biotech #7 and builds a diabetes pipeline with Ligand deal

8 years ago

Made in China: TaiMed wins FDA OK for a 'breakthrough' HIV therapy for drug-resistant patients

8 years ago

Faster, more convenient Opdivo dosing schedules gives Bristol-Myers added edge in battle of the PD-1 blockbusters with Merck

8 years ago

First page Previous page 305 306 307308309 310 311 Next page Last page